Related Articles
Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14)
Transient shrinkage of a uterine leiomyosarcoma treated with GnRH agonist for a presumed uterine leiomyoma: Comparison of magnetic resonance imaging finding before and during GnRH agonist treatment
Genes associated with the genesis of leiomyoma of the uterus in a commonly deleted chromosomal region at 7q22
A STUDY ON THE ONCOGENES GLI, FOS, JUN AND MET IN HUMAN UTERINE LEIOMYOMAS
Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix